The wild and woolly saga of the paper that claims to solve “the puzzle of the origin and evolution of cellular life in the universe” continues.
Yesterday, Ivan wrote on his Tumblr about Case Western’s Erik D. Andrulis‘ paper, “Theory of the Origin, Evolution, and Nature of Life:” Continue reading Case Western explains why it withdrew press release about Andrulis origin of life paper
The authors of a paper published last September in Blood about alleged links between certain genes and Hodgkin’s lymphoma have retracted it, after realizing they’d made mistakes in their calculations.
The retraction notice for “Multiple HLA class I and II associations in classical Hodgkin lymphoma and EBV status defined subgroups,” dated January 20 and signed by all of the authors, clearly explains what went wrong, taking pains to note that there was no misconduct involved: Continue reading Errors force retraction of Blood paper on genetics of Hodgkin’s lymphoma
Two crystallographers who retracted a Structure paper last year have retracted a study about a similar subject in the Proceedings of the National Academy of Sciences, for similar reasons.
Here’s the notice for the paper, which has been cited 23 times, according to Thomson Scientific’s Web of Knowledge: Continue reading PNAS retraction marks second for crystallography group
Dipak Das, the UConn red wine researcher charged by his institution with rampant misconduct that will likely lead to dozens of retractions, is evidently a 99%-er — when it comes to accuracy, that is.
According to a statement purportedly from his lawyer refuting those charges, Das claims, among other things, that the output from his lab was nearly perfect. He also has a lot to say about a 60,000-page report that the statement says he may not have actually downloaded.
We might note a lot more things about the letter, which we received from Bill Sardi, president of Longevinex, a resveratrol company which has worked with Das. Sardi has been sending Das defenses since the story broke; we posted some of them and Derek Lowe has posted parts of another. But here’s the letter, in its entirety: Continue reading Resveratrol researcher Dipak Das: My lab’s work was “99% correct”
When Renewable and Sustainable Energy Reviews accepted a paper last year arguing that nuclear power is Iran’s “assured right,” the editor, Lawrence Kazmirski, thought the article would be at least somewhat controversial. He was right — but for the wrong reason.
Shortly after publication, Kazmirski, director of the National Center for Photovoltaics at the National Renewable Energy Laboratory, in Golden, Colo., received an email from one of the listed co-authors of the article complaining that he and another co-author had not consented to submit the work. Kazmirski contacted the lead author, Afshin Mazandarani, who agreed to withdraw the paper.
The result was the following notice, which appeared in October (we only recently saw it): Continue reading Should Iran have nuclear power? Paper addressing question retracted for authorship issues
Following an investigation by the State University of New York (SUNY) Upstate into the work of one of its neuroscientists, the Journal of Neurochemistry has retracted a 2007 paper.
The retraction notice is quite clear about why the paper is being withdrawn: Continue reading Journal of Neurochemistry retracts paper after SUNY Upstate medical school finds evidence of fraud
The authors of a paper in the Journal of Biological Chemistry (JBC) have retracted it, but don’t ask us why.
This being the JBC, the retraction notice for “Human T-cell Leukemia Virus Type I Tax Down-regulates the Expression of Phosphatidylinositol 3,4,5-Trisphosphate Inositol Phosphatases via the NF-κB Pathway” is the very definition of opaque: Continue reading Mysterious retraction in the Journal of Biological Chemistry for Takashi Tsuji’s group
Three papers in Current Eye Research have apparently not quite lived up to the journal’s name. The journal in November retracted three studies from a group of authors in China who had previously published the papers in their native language.
Here’s the notice, which also appears in this month’s print edition: Continue reading Seeing double: Current Eye Research retracts three papers for duplication
Earlier this year we reported on the case of Bernardino Saccomanni, an apparently shameless plagiarist with a fondness for publishing in the orthopedics literature.
Somehow, we’re not surprised to learn that Saccomanni may not have been totally above board in other ways, too.
According to Robert Lindsay, editor of Osteoporosis International, whose journal has retracted one of Saccomanni’s plagiarized manuscripts, the researcher’s stated affiliation on several recent papers — Gabriele D’ Annunzio University Chieti — had long ago severed ties with him: Continue reading Orthopedics plagiarist may have lied about affiliation
Today, without us having planned it, has become the day of retracted papers that found a new home.
This morning, we posted an item about a chimp “culture” paper that was retracted from Biology Letters after its authors found some errors, and then published, with corrections, in the Journal of Human Evolution. This afternoon, we bring you the news of a PLoS ONE paper on longevity genes that is the corrected version of a Science paper retracted last year: Continue reading Sebastiani and Perls longevity genes work finds a new home in PLoS ONE following Science retraction